International Human Rights Speaker: Dr Christian Ntizimira

We are delighted to announce that Dr Christian Ntizimira (Rwanda) will address attendees at 19OPCC in a keynote about Transcultural palliative care consideration in global health delivery to bring human rights in the centre of positive change.

Dr Christian Ntizimira is a Masters Candidate at Harvard Medical School, Department of Global Health and Social Medicine, City Manager, Kigali, C/Can 2025 at Union for International Cancer Control (UICC) and the former Executive Secretary of the Rwanda Palliative Care and Hospice Organization (RPCHO).

Dr Ntizimira pioneered the integration of end-of-life care into health services rendered to Rwandan patients with chronic illnesses in acute care and community settings.  Through his program (2008-2013), more than 1500 health care providers and community health workers have learned the principles of cancer & palliative care leading to a five-fold increase in prescription of morphine, an essential pain medication.

This year he became the first advocacy/policy champion among extraordinary individuals are making a significant contribution to developing palliative care in low- and middle-income countries for World Hospice and Palliative Care Alliance (WHPCA).

From 2010–13, he was the Director of Kibagabaga Hospital in Kigali. He has advised several governments on national palliative care policy, including Burundi, Rwanda and Senegal, on access to palliative care services. He was a member of the Scientific Advisory Committee for the Lancet Commission on Global Access to Palliative Care and Pain Control 2014–17.

Dr Ntizimira graduated in medicine from the College of Medicine and Health Sciences at the University of Rwanda in 2008. In 2011, he received a scholarship to study palliative care education and practice in the United States of America at Harvard Medical School’s Center for Palliative Care. He also trained as an African Pain Policy Expert at the University of Wisconsin. He was named Young Cancer Leader by the Union for International Cancer Control in 2016 and Distinguished Young Leader by the Harvard Global Health Catalyst in 2017.